NCT06797934 Establishment of a Registry of Patients With Parathyroid Disease
| NCT ID | NCT06797934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Hyperparathyroidism |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2022-01-03 |
| Primary Completion | 2039-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,200 participants in total. It began in 2022-01-03 with a primary completion date of 2039-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Establishment of a registry with which to census all patients under the care of the O.U. Endocrinology for parathyroid pathology in order to longitudinally evaluate biochemical, clinical, radiological, medico-nuclear and histological data in future studies.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Diagnosis of hyperparathyroidism or hypoparathyroidism based on biochemical parameters (calcemia, parathormone, phosphormia, creatinine, albumin, vitamin D25OH) * Obtaining informed consent Exclusion Criteria: * none
Contact & Investigator
Uberto Pagotto, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06797934 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hyperparathyroidism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06797934 currently recruiting?
Yes, NCT06797934 is actively recruiting participants. Contact the research team at uberto.pagotto@unibo.it for enrollment information.
Where is the NCT06797934 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06797934 clinical trial?
NCT06797934 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Uberto Pagotto, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 1,200 participants.